Vor Biopharma Inc (NASDAQ: VOR) on Friday, plunged -3.01% from the previous trading day, before settling in for the closing price of $0.85. Within the past 52 weeks, VOR’s price has moved between $0.63 and $3.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 11.14%. With a float of $59.84 million, this company’s outstanding shares have now reached $68.66 million.
Let’s look at the performance matrix of the company that is accounted for 168 employees. In terms of profitability, gross margin is 77.63%, operating margin of -965.14%, and the pretax margin is -919.87%.
Vor Biopharma Inc (VOR) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vor Biopharma Inc is 12.86%, while institutional ownership is 58.87%. The most recent insider transaction that took place on Jun 03 ’24, was worth 20,357. In this transaction CHIEF MEDICAL OFFICER of this company sold 14,645 shares at a rate of $1.39, taking the stock ownership to the 96,063 shares.
Vor Biopharma Inc (VOR) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.14% per share during the next fiscal year.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Vor Biopharma Inc (VOR) is currently performing well based on its current performance indicators. A quick ratio of 4.69 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.65, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
Vor Biopharma Inc (NASDAQ: VOR) saw its 5-day average volume 0.47 million, a negative change from its year-to-date volume of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 45.91%. Additionally, its Average True Range was 0.07.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 33.86%, which indicates a significant decrease from 40.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.56% in the past 14 days, which was lower than the 76.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7731, while its 200-day Moving Average is $1.2469. Nevertheless, the first resistance level for the watch stands at $0.8600 in the near term. At $0.9004, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9304. If the price goes on to break the first support level at $0.7896, it is likely to go to the next support level at $0.7596. The third support level lies at $0.7192 if the price breaches the second support level.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
Market capitalization of the company is 54.59 million based on 68,674K outstanding shares. Right now, sales total 0 K and income totals -117,863 K. The company made 0 K in profit during its latest quarter, and -27,559 K in sales during its previous quarter.
